prior knowledge of the clinical diagnosis or origin of the sample.
1. Counter-immunoelectrophoresis (CIE) using a low voltage technique employing 09 % agarose in 0 05 M-sodium barbitone at pH 8-6 and a current of 20 mA for 75 minutes. Two antisera were used: a monkey antiserum with predominantly ay specificity, and a human antiserum with ad specificity. 2. Solid phase radioimmunoassay (RIA) using the Ausria II-125 diagnostic kit (Abbott Laboratories). Sensitivity has been improved by providing a greater surface area for the attachment of protein by using a small plastic bead about 6 mm in diameter as the solid phase. The bead is coated with guineapig antibody to HBsAg. Specificity has also been improved by using human '25I-labelled hepatitis-B surface antibody (HBsAb) . Radioactivity counts of test samples are compared with those of positive and negative controls, and the test is valid if the positive control is greater than five times the negative control. Positive results are confirmed by demonstrating neutralization by a specific human antiserum.
3. Three distinct direct haemagglutination tests based on the principles of reversed passive haemagglutination (Juji and Yokochi, 1969): a. Auscell (Abbott Laboratories) using specially prepared, stabilized human erythrocytes sensitized with guinea-pig antibody to HBsAg. The test is carried out in disposable rigid V-bottomed Microtitre plates (Cooke Instruments Ltd.), and agglutination patterns read after two hours' incubation at room temperature. Samples are screened at a dilution of 1 in 16, and positive and negative controls are included. Care is needed by the inexperienced in interpreting the results. Positives are Chrystie et al., 1974) . Microtitre U-bottomed plates are used and, as nucleated erythrocytes settle quickly, the results can be read after 30 minutes' incubation at room temperature. Samples are screened at a dilution of 1 in 10.
c. Hepanosticon (Organon Teknika) using sensitized sheep erythrocytes (Reesink et al., 1973) .
Only 10 ,ul serum or plasma is required and this is added to a 500 ,ul volume of cell suspension in disposable glass sedimentation tubes. The pattern of agglutination is read from below, using a special rack with angled mirror, after three hours' incubation at room temperature. Positives are retested after absorption with a specially provided absorbent. HBsAg was detected by CIE in only three patients (3 3%), the number of positives being increased using the more sensitive tests, RIA again being the most sensitive. There was very little difference in the sensitivity of the three haemagglutination tests, Hepanosticon missed two sera which were positive by Auscell and Hepatest, and similarly Hepatest missed one positive which was picked up by the other two haemagglutination tests. The overall incidence of positive tests was eight (8 8%), only two of which were positive by RIA alone.
Results

Discussion
An overall incidence of 58% positive HBsAg in a group of patients with cirrhosis in Iraq is very much higher than has been reported from any other part of the world. A figure of 265% was found on testing by CIE alone and this may be compared with the findings of Anthony et al. (1972) who reported 32 9% positives in a group of cirrhotics from Uganda using counter electrophoresis and complement fixation, and of Bagshawe et al. (1971) from Kenya, who found a positive rate of 20-5 % with gel diffusion. Reed et al. (1973) using radioimmunoassay, found 26 % positives in a small number of patients with cryptogenic cirrhosis but these included both British and foreign nationals. The number of positive reactions in cirrhotics from the Far East tested by counter immunoelectrophoresis appeared to be far lower (Whittingham etal. 1973 ). The more sensitive tests for HBsAg detected approximately twice as many positives as CIE. The prevalence rate among the hospital controls (3 3 % by CIE) agrees closely with a figure of 3-6 % positives among blood donors in Iraq by counter immunoelectrophoresis (Skinh0j and Al-Kassab, 1973) . Even by the most sensitive technique (8-8 % by RIA), this value is nowhere near the figure found in patients with cirrhosis.
Using the same group of tests in 66 patients with cirrhosis in Birmingham we found 7-6 % positive by RIA and 3 % by the other four methods (unpublished observations). Since the majority were alcoholic (Jain et al., 1973) , it will take time to test enough patients with cryptogenic cirrhosis, but it is most unlikely that the frequency of HBsAg will be as high as in Iraq.
The significance of the present findings remains to be determined. The majority (88 %) of the small number of sera tested belonged to the ay subtype, which is thought to predominate in the Middle East, and was found in all the samples tested by Skinh0j and Al-Kassab (1973) . Further subtyping is being carried out by Dr G. Le Bouvier and his colleagues.
Although the incidence of HBsAg in the Iraqi patients with cirrhosis is far higher than in the general population in Iraq and in Great Britain, it cannot yet be assumed that the presence of antigen necessarily indicates that hepatitis-B virus is the cause of the disease. However, a detailed survey of the patients seen in Baghdad (Rassam and Paton, to be published) has so far failed to reveal any aetiological factor, other than alcohol in a few; in particular, malnutrition and bilharziasis could be excluded as important causes. Moreover, cirrhosis differs in at least two other important respects from that seen in the West: haematological changes usually designated as 'hypersplenism' are twice as frequent and the y-globulin fraction of the plasma proteins is often markedly raised. The possibility of an abnormal immune response is at present under investigation. If it could be shown that nearly 60% of cirrhosis in Iraq, and other countries in the Middle East and Africa, is caused by the hepatitis virus, this would represent a significant advance in understanding a common disease whose aetiology is at present obscure. 
